The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bionomics(NASDAQ:BNOX)


Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the ...
Website: https://www.bionomics.com.au
Founded: 1996
IPO Price: $12.35 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Bionomics Days Payable Outstanding ttm (DPO)
Bionomics Days Receivable Outstanding ttm (DSO)
Bionomics Op Cashflow Per Share ttm
Bionomics Free Cashflow Per Share ttm
Bionomics Cash Per Share ttm
Bionomics P/S ratio ttm
Bionomics (GAAP) P/E ratio ttm
Bionomics P/B ratio ttm
No extra charts and metrics for this ticker.